| Heading: |
Mifepristone: Side Effects |
| Question ID: |
1809755 |
| UIN: |
57621 |
| House: |
Commons |
| Date tabled: |
2025-06-05 |
| Asking Member ID: |
1593 |
| Asking Member display name: |
Sammy Wilson
|
| Asking Member handle: |
eastantrimmp
|
| Asking Member Twitter reference: |
@eastantrimmp
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, how many (a) serious but non-fatal and (b) fatal adverse reactions associated with the use of mifepristone have been reported to the Medicines and Healthcare products Regulatory Agency in each of t |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-06-20 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4444 |
| Answering Member display name: |
Karin Smyth
|
| Answering Member handle: |
karinsmyth
|
| Answering Member Twitter reference: |
@karinsmyth
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for ensuring medicines, medical devices, and blood components for transfusion meet applicable standards of safety, quality, and efficacy. The MHRA rigorously assesses available ... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |